Must written procedures be available to prevent objectionable microorganisms in drug products not required to be sterile?

Yes. Appropriate written procedures, designed to prevent objectionable microorganisms in drug
products not required to be sterile, should be established and followed. This means that even though a drug
product is not sterile, a firm must follow written procedures that proactively prevent contamination and
proliferation of microorganisms that are objectionable.